@misc{indiciae360b434a7c7f,
  title = {The novel RNA polymerase I transcription inhibitor PMR-116 exploits a critical therapeutic vulnerability in a broad-spectrum of high MYC malignancies.},
  author = {Ferreira, R. and Hannan, K. M. and Panov, K. and Udumanne, T. and George, A. J. and Closa, A. and Yuen, Z. and Eyras, E. and Poh, P. and Maclachlan, K. and Dwyer, M. and Barn, V. and He, J. and Kusnadi, E. and Rebello, R. and Huglo, A. and Hedwards, S. and Lawrence, M. and Risbridger, G. and Taylor, R. and Clark, A. and Farrell, G. and Pok, S. and Teoh, N. and Amarasini, M. and Norcott, P. L. and Banwell, M. G. and Manenkova, Y. and Haddach, M. and Drygin, D. and Furic, L. and Hannan, R. D. and Hein, N.},
  year = {2025},
  doi = {10.1101/2025.04.19.649466},
  url = {https://www.biorxiv.org/content/10.1101/2025.04.19.649466v1},
  note = {Source identifier: 10.1101/2025.04.19.649466}
}